Sumitomo Mitsui Trust Holdings, Inc. Gilead Sciences, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $142 Billion
- Q3 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 3,023,984 shares of GILD stock, worth $273 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,023,984
Previous 2,968,143
1.88%
Holding current value
$273 Million
Previous $204 Million
24.47%
% of portfolio
0.18%
Previous 0.15%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
1,923Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.4 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.9 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.57 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.43 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $113B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...